# Alife

> Publicly sourced profile assembled by Optimly, in the Optimly AI Brand Index. Last refreshed 2026-10-04.

- **Business Profile:** https://optimly.ai/brand/alife
- **Dataset:** https://optimly.ai/brand/alife.json
- **Markdown:** https://optimly.ai/brand/alife/llms.txt
- **Official website:** https://alifehealth.com
- **Slug:** alife
- **Categories:** ai-machine-learning, healthcare-it

## Overview

- **Tagline:** Features Embryo Predict, the first commercially available FDA-cleared AI tool for embryo assessment in IVF in the U.S., supported by multi-center randomized clinical trials and peer-reviewed research.
Source: Brand's website (https://alifehealth.com) · 2026-10-04

- **Description:** Alife is a company developing AI-powered software and technology for In Vitro Fertilization (IVF) to assist clinics and patients in improving outcomes and operational efficiencies. Their platform includes tools for embryo assessment, clinic scheduling, and patient conversion.
Source: Brand's website (https://alifehealth.com) · 2026-10-04

## Offerings

- **Core capabilities:**
  - AI-powered software platform for IVF clinics
  - including Embryo Predict (AI embryo assessment)
  - Schedule Predict (clinic efficiency)
  - Success Predictor (patient conversion)
  - Alife Assist™ configurable platform
  - Alife App for patients
  - and an IVF Calculator.
Source: Brand's website (https://alifehealth.com) · 2026-10-04

## Audience

- **Target industry:** IVF clinics, fertility leaders, embryologists, reproductive endocrinologists, and patients undergoing fertility treatment in the U.S. and Europe.
Source: Brand's website (https://alifehealth.com) · 2026-10-04

Page last updated 2026-10-17.